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Edited by Sandro SonninoAbstract Membrane disruption by oligomeric a-synuclein (aS)
is considered a likely mechanism of cytotoxicity in Parkinsons
disease (PD). However, the mechanism of oligomer binding
and the relation between binding and membrane disruption is
not known. We have visualized aS oligomer-lipid binding by ﬂuo-
rescence microscopy and have measured membrane disruption
using a dye release assay. The data reveal that oligomeric aS
selectively binds to membranes containing anionic lipids and
preferentially accumulates into liquid disordered (Ld) domains.
Furthermore, we show that binding of oligomers to the mem-
brane and disruption of the membrane require diﬀerent lipid
properties. Thus membrane-bound oligomeric aS does not al-
ways cause bilayer disruption.
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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a-Synuclein (aS) is a 140 amino acid protein abundantly ex-
pressed throughout the central nervous system [1] and is likely
to be involved in the pathogenesis of Parkinsons disease (PD).
It is the major constituent of Lewy bodies found in PD [2] and
three mutant forms of the protein, that lead to a rare familial
form of PD, have been identiﬁed [3–5]. In vitro, aS is an intrin-
sically disordered protein with little secondary structure [6].
Although the role of aS in the cell is not known, lipid binding
is thought to be involved in its function [7]. Under speciﬁc con-
ditions, aS aggregates into densely packed b-sheet rich ﬁbrils,
similar to those found in vivo [8]. Monomeric aS can bind to
negatively charged phospholipid vesicles in the liquid disor-
dered (Ld) phase [9–11]. Binding of aS monomers to mem-Abbreviations: aS, a-synuclein; PD, Parkinsons disease; Ld, liquid
disordered; Lo, liquid ordered; GUVs, giant unilamellar vesicles;
LUVs, large unilamellar vesicles; wt, wild-type; AL488, Alexa 488;
POPC, 1-palmitoyl, 2-oleoyl phosphatidylcholine; POPG, 1-palmitoyl,
2-oleoyl phosphatidylglycerol; DPPG, 1,2-dipalmitoyl phosphatidyl-
glycerol; 18:2-PG, 1,2-dilinoleoyl phosphatidylglycerol; POPS, 1-pal-
mitoyl, 2-oleoyl phosphatidylserine; DOPA, 1,2-dioleoyl phosphatidic
acid; DOPE-Rhod, 1,2-dioleoyl phosphatidylethanolamine-(lissamine
rhodamine B); Chol, cholesterol
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helical conformation [12]. It is often suggested that a gain of
toxic function of aS relates the protein to PD [7]. However,
the mechanism of toxicity and the relation between aggrega-
tion, lipid binding and toxicity is not unequivocally established
[13–16]. In recent years, oligomeric intermediates in the aggre-
gation of aS are considered as a likely toxic species [17,18].
Membrane disruption and subsequent calcium leakage have
been suggested as a possible mechanism of oligomer toxicity
[14]. In vitro, oligomeric aS can permeabilize lipid vesicles,
possibly through a pore-like mechanism [19–21]. However,
surprisingly little is known about the lipid binding properties
of oligomeric aS. Using confocal ﬂuorescence microscopy
and a dye release assay we investigated the relation between li-
pid binding and membrane disruption by oligomeric aS. Con-
focal microscopy images of giant unilamellar vesicles (GUVs)
and ﬂuorescently labeled oligomeric aS indicate that oligomers
preferentially bind to GUVs composed of anionic phospholip-
ids in the Ld phase. Furthermore, we observe that the binding
of oligomers to the negatively charged vesicle bilayer does not
result in membrane permeabilization for all lipid compositions.2. Materials and methods
2.1. Puriﬁcation of aS
Since wild-type (wt) aS does not contain any cysteine residues neces-
sary for ﬂuorescent labeling, an alanine to cysteine mutation was intro-
duced at residue 140. aS-wt and the aS-A140C mutant were expressed
in Escherichia coli strain BL21(DE3) using the pT7-7 expression plas-
mid and puriﬁed in the presence of 1 mM DTT as previously reported
[22].
2.2. aS labeling
Prior to labeling, aS-A140C was reduced with a ﬁve-fold molar ex-
cess of DTT for 30 min at room temperature. The samples were de-
salted with Pierce Zeba desalting columns, followed by the addition
of a two-fold molar excess of Alexa 488 (AL488) C5 maleimide dye
(Invitrogen) and incubated for one hour in the dark at room temper-
ature. Free label was removed using two desalting steps. The protein
labeling eﬃciency was estimated to be 80% from the absorption spec-
trum.
2.3. Oligomer preparation
aS-wt was mixed with aS-A140C-AL488 at a 7:1 ratio in 10 mM
Tris–HCl, pH 7.4 and lyophilized. The protein was redissolved at a
concentration of 1 mM using MilliQ water and incubated for 16 h in
the dark in an Eppendorf thermomixer at 500 rpm at room tempera-
ture. The oligomer containing sample was ﬁltered through a 0.2 lm
Spin-X centrifugal ﬁlter (Corning) to remove possible larger aggre-
gates. Oligomeric species were then puriﬁed on a Superdex 200 (GE)
gel ﬁltration column using 10 mM HEPES pH 7.4, 150 mM NaCl asblished by Elsevier B.V. All rights reserved.
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pooled and concentrated using a Vivaspin (Sartorius) concentrator
with 10 kDa molecular weight cutoﬀ. The oligomer concentration
and ﬁnal labeling ratio were determined from the absorption spectra.
Generally, stock solutions with a concentration of 20 lM (equivalent
monomer concentration) and 10–15% labeling were obtained.
2.4. Vesicle preparation
1-Palmitoyl, 2-oleoyl phosphatidylcholine (POPC), 1-palmitoyl,
2-oleoyl phosphatidylglycerol (POPG), 1,2-dipalmitoyl phosphatidyl-
glycerol (DPPG), 1,2-dilinoleoyl phosphatidylglycerol (18:2-PG),
1-palmitoyl, 2-oleoyl phosphatidylserine (POPS), 1,2-dioleoyl phos-
phatidic acid (DOPA), 1,2-dioleoyl phosphatidylethanolamine-
(lissamine rhodamine B) (DOPE-Rhod) and cholesterol (Chol) were
obtained from Avanti Polar lipids. Vesicles of various compositions
were prepared by mixing the lipids from stock solutions in chloroform.
0.05% DOPE-Rhod was added to all compositions. GUVs containing
anionic lipids were created by gentle hydration. Approximately 0.5 mg
of lipid was deposited in a glass vial and dried using nitrogen gas.
Residual chloroform was removed by drying under vacuum for 4 h.
The lipid ﬁlm was hydrated for 6 h at room temperature in 500 ll of
sucrose solution of equal osmolarity to 10 mM HEPES pH 7.4,
150 mM NaCl. GUVs containing saturated lipids were hydrated at
50 C. Electroswelling [23] was used to prepare POPC GUVs. A dried
lipid ﬁlm was prepared on the conducting side of an ITO coated slide
and joined with a second ITO slide separated by a spacer and hydrated
overnight at room temperature in 400 ll of sucrose solution in the
presence of an AC electric ﬁeld (1 V/mm, 10 Hz).
2.5. Confocal microscopy
Confocal microscopy was performed on a Zeiss LSM 510 confocal
microscope. DOPE-Rhod was excited at 543 nm using a green He–
Ne laser and aS-AL488 was excited using the 488 nm Argon laser line.
Fluorescence was detected using multitrack imaging to minimize cross-
talk. GUVs were diluted to approximately 60 lM in 10 mM HEPES,
pH 7.4, 150 mM NaCl and mixed with ﬂuorescently labeled oligomeric
aS at a 1 lM concentration (equivalent monomer concentration). In
the quantitive binding experiments all images were acquired at exactly
the same instrument settings. The amount of binding was quantiﬁed
from the GUV images as the maximum value of the radial proﬁle.
For each data point images of at least 15 GUVs were acquired. The
experiment was performed twice.
2.6. Dye release assay
To prepare large unilamellar vesicles (LUVs), a lipid ﬁlm was
formed by drying 0.5 mg of lipid. The lipid ﬁlm was hydrated for
1 h, with regular vortexing in a solution of 50 mM calcein (Sigma),
10 mM HEPES, pH 7.4. To prevent osmotic pressure diﬀerences be-
tween the vesicle interior and the solution outside, NaCl was added
to maintain an osmotic strength equal to 10 mM HEPES, pH 7.4,
150 mM NaCl. The sample went through 5 freeze-thaw cycles and
was then extruded 11 times through a 100 nm polycarbonate mem-
brane ﬁlter. The extrusion procedure was repeated twice. Unencapsu-
lated dye was removed by gel ﬁltration through a column packed with
Sephadex G-100 (GE). Finally, the phospholipid concentration was
determined [24]. For the eﬄux assay the vesicle solution was mixed
with an equal volume of protein solution. After 30 min incubation,
the maximum intensity of the ﬂuorescence emission spectrum for exci-
tation at 497 nm was recorded on a Varian Cary Eclipse ﬂuorimeter.
After background subtraction, leakage was expressed as a percentage
of the maximum eﬀect induced by the addition of 0.5% (w/v) Triton
X-100.Fig. 1. Confocal Microscopy images of DOPE-Rhod labeled GUVs
(left panels) and aS-A140C-AL488 oligomers (right panels). The scale
bars indicate 5 lm. The lipid compositions of the GUVs were: (A)
POPG:Chol 5:1, (B) DOPA:Chol 5:1, (C) POPS:Chol 5:1, and (D)
POPC.3. Results
3.1. Lipid binding headgroup speciﬁcity
To obtain ﬂuorescently labeled oligomers, aS-A140C-AL488
was aggregated with aS-wt in a 1:7 ratio. Labeled aS eﬃciently
incorporated into the oligomeric species and the labeling ratio
was spectroscopically determined to be 10–15%. After puriﬁca-
tion no monomeric aS could be detected in the oligomer solu-tion by native gradient PAGE (Supplementary information,
Fig. S1). The labeled oligomers migrated at a similar molecular
weight as aS-wt oligomers and showed a comparable tendency
to disrupt POPG vesicles as the unlabeled species (Supple-
mentary information, Fig. S2). It can therefore be concluded
that the introduction of aS-A140C-AL488 does not aﬀect the
oligomer properties.
The binding of oligomers to GUVs was studied using confo-
cal ﬂuorescence microscopy. First GUVs from diﬀerent anio-
nic lipids with 20% cholesterol were prepared. Labeled aS
clearly showed binding to these negatively charged GUVs
(Fig. 1A–C). GUV morphology was not aﬀected by binding
of oligomeric aS and the GUVs remained stable during the
time of the experiment. Binding of aS oligomers to neutrally
Fig. 3. Calcein release from LUVs (open symbols, dotted lines) and
binding to GUVs (closed symbols, solid lines) from POPC:DOPA
(grey circles) and POPC:POPG vesicles (black triangles) at a lipid
concentration of 40 lM and at diﬀerent aS-A140C-AL488 concentra-
tions (oligomer concentration is expressed in equivalent monomer
concentration). The error bars denote the standard deviation (n = 2).
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ing the protein to lipid ratio 12 times to 1:5 did not change
this observation.
To further investigate the speciﬁcity for negatively charged
headgroups, mixtures of POPC and anionic phospholipids in
a 1:1 ratio were used (Fig. 2). The aS oligomers showed bind-
ing to POPC:DOPA and POPC:POPG GUVs but much lower
binding was detected to POPC:POPS.
3.2. Oligomer membrane permeabilization
The lipid disruption properties of oligomeric aS critically de-
pend on the lipid headgroup composition [20]. To investigate if
this originates from a diﬀerent binding aﬃnity or, for instance,
a diﬀerent mode of binding, a dye release assay together with a
quantitive binding experiment was performed. The results
shown in Fig. 3 indicate that POPC:POPG LUVs are not per-
meabilized whereas POPC:DOPA LUVs showed a concentra-
tion dependent calcein release upon addition of oligomeric aS.
Next labeled aS oligomers were added to POPC:POPG and
POPC:DOPA GUVs at diﬀerent concentrations and binding
was quantiﬁed from the confocal images. These results indicate
that aS oligomers bind POPC:DOPA with higher aﬃnity than
POPC:POPG but the diﬀerence in binding aﬃnity is much
smaller than the diﬀerence in permeabilization properties.Fig. 2. Confocal microscopy images of DOPE-Rhod labeled GUVs
from 1:1 mixture of anionic lipids with POPC (left panels) and aS-
A140C-AL488 oligomers (right panels). The scale bars indicate 5 lm.
The lipid compositions of the GUVs were, (A) POPC:POPG, (B)
POPC: POPS, and (C) POPC:DOPA.3.3. Lipid binding phase speciﬁcity
Lipid packing can be a critical parameter in determining
protein lipid interactions. We have previously observed (van
Rooijen et al., submitted) that vesicle disruption by oligomeric
aS is sensitive to lipid packing. Denser packed membranes
were found to be less sensitive to disruption. Lipids in the li-
quid ordered (Lo) phase are much more densely packed than
lipids in the Ld phase. Thus the eﬀect of lipid phase on aS oli-
gomer-lipid binding was examined. A binding speciﬁcity to Ld
or Lo phases can be observed by examining binding to GUVs
containing coexisting domains [25]. This can be visualized
since DOPE-Rhod preferentially accumulates in Ld domains
[26]. 18:2-PG:DPPG:Chol GUVs were prepared and formation
of segregated Ld and Lo domains was observed (Fig. 4A).
Labeled aS oligomers preferentially accumulated in the
DOPE-Rhod rich domains. This speciﬁcity for Ld domains
was so strong that it was also observed using wideﬁeld ﬂuores-Fig. 4. Confocal microscopy image (A) and wide ﬁeld ﬂuorescence
microscopy image (B) of DOPE-Rhod labeled DLPG:DPPG:Chol
1:1:1GUVs (left panels) and aS-A140C-AL488 oligomers (right
panels). The scale bar indicates 5 lm.
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compositions containing only lipids in an ordered phase, no
oligomer binding could be detected (Supplementary informa-
tion, Fig. S3). Oligomeric aS thus preferentially binds to lipids
in the Ld phase.4. Discussion
4.1. aS Oligomers only bind to anionic lipids
aS oligomers preferentially bind to GUVs consisting of an-
ionic lipids and no binding was detected to zwitterionic POPC
GUVs. Oligomer binding was observed in mixtures of anionic
lipids and POPC. Although oligomeric aS showed binding to
POPC:POPG and POPC:DOPA GUVs, little binding to
POPC:POPS was observed. Diﬀerences in lipid headgroup
structure might be responsible for the lower apparent aﬃnity
of aS oligomers for POPS in mixed GUVs. The binding pref-
erence for anionic lipids agrees with an earlier report, indicat-
ing binding to PG and PC:PA but not to PC [21]. However,
these authors did not check binding to other lipids and lipid
mixtures. Others have reported oligomer binding [27] to the
zwitterionic lipid PC. A potential explanation is that diﬀerent
intermediates in the aggregation of aS could possess diﬀerent
lipid binding properties. Detailed binding studies require stable
puriﬁed samples. For earlier intermediates in the aggregation
this might be technically challenging.
4.2. Binding does not always lead to permeabilization
In spite of the observation that aS oligomers bind POPC:
POPG GUVs, our dye release experiments show that the
POPC:POPG LUVs are not permeabilized. The quantitive
imaging experiment revealed a smaller binding aﬃnity for
POPC:POPG. However this diﬀerence is too small to explain
why POPC:POPG LUVs are not aﬀected even at high oligo-
mer concentrations. Thus, binding of aS oligomers to the
membrane does not necessarily lead to membrane permeabili-
zation. We postulate that membrane disruption is a two step
process in which the initial binding and the subsequent disrup-
tion require diﬀerent lipid properties. The mechanism of per-
meabilization is currently still debated [19,20,28]. When
comparing the concentration dependence of leakage with the
binding curves it appears that the oligomers do not need to sat-
urate the membranes before leakage occurs, which is consistent
with a pore model. However, one must be cautious in compar-
ing the GUV and LUV systems.
4.3. aS Oligomers only bind to Ld domains
Lipid packing is an important parameter in determining pro-
tein-lipid interactions. We have previously shown that bilayer
disruption is sensitive to the accessibility of the hydrophobic
bilayer core (van Rooijen et al., submitted). The results pre-
sented here are consistent with these data, and show that aS
oligomers preferentially bind to lipids in the Ld phase, and
do not show aﬃnity for Lo bilayers. In the Lo phase lipids
are much more densely packed with the lipid tails extended
and a reduced area per headgroup. Possibly, the higher surface
charge density in the Lo phase makes it energetically unfavor-
able for the negatively charged aS to adsorb on the membrane.
Alternatively steric hindrance or inaccessibility of the mem-
brane hydrophobic core oﬀer possible explanations for why
oligomeric aS does not bind to the Lo phase. Interestingly,monomeric aS has a similar binding speciﬁcity for anionic lip-
ids in the Ld phase [9,10]. Lipid binding of monomeric aS oc-
curs at residues 1–100 [12]. Although the protein has a net
negative charge, the N-terminal residues contain many hydro-
phobic and positively charged amino acids, explaining the
speciﬁcity for anionic lipids. The similar speciﬁcity for oligo-
meric aS could suggest that in the oligomers, the N-terminal
is available for lipid binding. We have not found evidence
for a structural reorganization of aS oligomers upon lipid
interaction by circular dichroism spectroscopy, consistent with
earlier work [21]. Folding of the N-terminus into a helical con-
formation upon lipid binding, as occurs with monomeric aS, is
therefore unlikely for oligomeric aS.
Summarizing, we have systematically studied the lipid bind-
ing properties of oligomeric aS and its relation to bilayer dis-
ruption. The data show that oligomeric aS preferentially binds
to anionic lipids in the Ld phase. Furthermore, binding does
not lead to membrane disruption for all lipid compositions,
which suggests that binding and disruption are distinct pro-
cesses.
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